These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26818106)

  • 1. Pre-operative PCC for non-bleeding patients on warfarin.
    Bucko AM; Makris M
    Thromb Res; 2016 Mar; 139():158-9. PubMed ID: 26818106
    [No Abstract]   [Full Text] [Related]  

  • 2. Periprocedural warfarin reversal with prothrombin complex concentrate.
    Sridharan M; Wysokinski WE; Pruthi R; Oyen L; Freeman WD; Rabinstein AA; McBane RD
    Thromb Res; 2016 Mar; 139():160-5. PubMed ID: 26657301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dangers of prothrombin complex concentrate administration after heart surgery.
    White R; Rushbrook J; McGoldrick J
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):609-10. PubMed ID: 18685448
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage.
    Kuwashiro T; Yasaka M; Itabashi R; Nakagaki H; Miyashita F; Naritomi H; Minematsu K
    Cerebrovasc Dis; 2011; 31(2):170-6. PubMed ID: 21135553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of activated prothrombin complex concentrate for the reversal of vitamin K antagonist major bleeding.
    Sheikh-Taha M; Crawley RM
    Sci Rep; 2022 Feb; 12(1):1814. PubMed ID: 35110612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for Warfarin Reversal-A Critical Appraisal of the Evidence.
    Jones GM; Davidson KE
    Am J Ther; 2018; 25(3):e375-e377. PubMed ID: 29227291
    [No Abstract]   [Full Text] [Related]  

  • 8. [Practical treatment of warfarin associated coagulation disorder].
    Garcia D; Crowther MA; Ageno W
    Praxis (Bern 1994); 2010 Dec; 99(25):1569-73. PubMed ID: 21157725
    [No Abstract]   [Full Text] [Related]  

  • 9. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.
    Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S
    Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin complex concentrate for warfarin-induced bleeding in a patient with a mechanical aortic valve.
    Kar R; Abel E; Burcham P; Firstenberg MS
    Interact Cardiovasc Thorac Surg; 2013 Aug; 17(2):421-2. PubMed ID: 23667067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What happens after prothrombin complex concentrate administration?
    Horton S; Heath R; Houghton A; Martlew V; Thachil J
    Eur J Intern Med; 2013 Apr; 24(3):e48-9. PubMed ID: 23044171
    [No Abstract]   [Full Text] [Related]  

  • 12. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).
    Pernod G; Godiér A; Gozalo C; Tremey B; Sié P;
    Thromb Res; 2010 Sep; 126(3):e167-74. PubMed ID: 20630568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience on using prothrombin complex concentrate in urgent warfarin reversal: an Iranian survey.
    Haghpanah S; Karimi M; Bordbar M; Kamfiroozi R; Asgharzadeh H
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):277-81. PubMed ID: 22734101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy.
    Majeed A; Eelde A; Agren A; Schulman S; Holmström M
    Thromb Res; 2012 Feb; 129(2):146-51. PubMed ID: 21807399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom.
    Guest JF; Watson HG; Limaye S
    Clin Ther; 2010 Dec; 32(14):2478-93. PubMed ID: 21353116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation interruptus: not without risk.
    Ezekowitz MD
    Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of anticoagulation before and after procedures.
    Spandorfer J
    Med Clin North Am; 2001 Sep; 85(5):1109-16, v. PubMed ID: 11565488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Massive metrorrhagia in a patient under warfarin anticoagulation. Rapid reversal with a concentrated prothrombin complex (Prothromplex Immuno TIM 4 600 IU)].
    Fuentes Pradera MA; Suárez Delgado JM; Yanes Vidal G; Yerga Pozo G
    Rev Esp Anestesiol Reanim; 2006 Dec; 53(10):669-71. PubMed ID: 17302086
    [No Abstract]   [Full Text] [Related]  

  • 19. Periprocedural management of anticoagulation in patients on extended warfarin therapy.
    Jafri SM; Mehta TP
    Semin Thromb Hemost; 2004 Dec; 30(6):657-64. PubMed ID: 15630672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory assessment of warfarin reversal with global coagulation tests versus international normalized ratio in patients with intracranial bleeding.
    Voils SA; Martin EJ; Mohammed BM; Bayrlee A; Brophy DF
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):443-7. PubMed ID: 25699612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.